Navigation Links
Surefire Medical's Anti-Reflux Infusion System May Eliminate Coiling, Lower Cost Of Embolization Procedures
Date:9/16/2013

WESTMINSTER, Colo., Sept. 16, 2013 /PRNewswire/ -- Surefire Medical, Inc., the developer of a brand new class of infusion systems designed to maximize direct-to-tumor drug delivery without reflux, today announced that presentations at the Cardiovascular and Interventional Radiological Society (CIRSE) meeting make the economic case for use of the new Surefire Infusion System (SIS).   Research presented today in Barcelona found that:

  • The SIS catheter group had a significant reduction in procedure time, fluoroscopy time, and contrast dose in pre-treatment angiograms
  • Without use of coils, no non-target embolization occurred in the SIS group during treatment
  • Using the SIS catheter to protect non-target organs costs significantly less than coil embolization in direct-to-tumor cancer treatment

"The Surefire Infusion System is a viable first-line alternative to traditional retrievable coil embolization for protecting non-target organs and may lead to decreased overall costs, procedure time, fluoroscopy time, and contrast exposure when treating cancer patients with radioembolization," said principal investigator Steven Kikolski, MD of the University of California San Diego (UCSD).

Additional SIS-focused presentations at CIRSE

Five additional presentations and posters at CIRSE focusing on the Surefire Infusion System

  • Confirm the safety of performing chemoembolization and radioembolization procedures without coiling
  • Present a pilot study of a single procedure for mapping and radioembolization
  • Detail the new ability to measure blood pressure changes that can signal the endpoint of embolization
  • Discuss the feasi
    '/>"/>

SOURCE Surefire Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Surefire Medical Launches Next Generation Infusion System ST-LT and Specialty Catheters at SIR - Maximizing Targeted Delivery of Embolics Without Reflux
2. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
3. At RSNA, DR Systems Will Exhibit RIS, Reporting, Peer Review Systems
4. Clionsky Neuro Systems (CNS-Neuro) Announces Publication of Study Finding Elderly Patients Unable to Recognize Their Memory Loss
5. Dicom Systems and USARAD.com Announce Partnership and Introduce Beta Version of XMRI.com, New System by USARAD.com
6. Ellmans Pelleve™ Wrinkle Reduction System featured in "Sexy Eyes" segment on The Doctors
7. Bacterin Signs Distribution Agreement with Jeil for LeForte Craniomaxillofacial System
8. BioPower Systems Awarded $5 Million from Victorian Government
9. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
10. Varian Medical Systems Schedules First Quarter FY2012 News Release and Conference Call
11. Quanterix Develops Microfluidic Consumable That Will Enable Next Generation Molecular Diagnostic Systems based on Single Molecule Array Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... DUBLIN , Sept. 18, 2014 ... the "Global and Chinese Stem Cell Industry Report, ... Stem cells are undifferentiated biological cells that can differentiate ... produce more stem cells. Stem cell therapy can be ... of hematological system disease), nervous system diseases, damage or ...
(Date:9/18/2014)... Research and Markets has announced ... Report 2014" report to their offering. ... a professional and in-depth study on the current state ... report provides a basic overview of the industry including ... albumin market analysis is provided for the international markets ...
(Date:9/18/2014)... 18, 2014 Leatherwood Plastics has ... material, to stay competitive in the semiconductor, clean ... materials ultimately impact product quality and productivity, according ... , Established in 1980 in Lewisville, TX, ... fabricators have left the business. Much of Leatherwood’s ...
(Date:9/18/2014)...  MEI Pharma, Inc. (Nasdaq: MEIP ), an ... for cancer, announced today that Daniel P. Gold , ... NewsMakers in the Biotech Industry conference on Friday, ... Millennium Broadway Hotel & Conference Center in New ... be accessed at www.meipharma.com . A replay will be ...
Breaking Biology Technology:Global and Chinese Stem Cell Industry Report, 2014-2017 2Global and Chinese Stem Cell Industry Report, 2014-2017 3Global Human Albumin Industry Report 2014 2Global Human Albumin Industry Report 2014 3Leatherwood Plastics Selects Vycom’s Flametec PVC-C Material to Stay Competitive in Semiconductor and Lab Equipment Industries 2MEI Pharma To Present At BioCentury's NewsMakers Conference 2MEI Pharma To Present At BioCentury's NewsMakers Conference 3
... Close Completes $35 Million Financing, WOBURN, Mass., Nov. ... generation biologics for the treatment and,prevention of cancer and ... financing, concurrent with the completion of a,venture debt transaction, ... intends to use the capital to complete its preparations ...
... for,U-Md. Bioscience Day, COLLEGE PARK, Md., Nov. 14 ... technology enabling him to develop an,infinite variety of safe, ... capitalists and the title of "Best Inventor Pitch" at ... university,s Office of Technology Commercialization,the College of Chemical and ...
... Inc. (Nasdaq: ADLS ), a biopharmaceutical company ... drugs in the,therapeutic areas of infection, cancer and ... third quarter ended September 30,2007. (Logo: ... three months ended September 30, 2007 was $5.8,million ...
Cached Biology Technology:BioVex Closes Second Round of Series E Financing 2Pure Plastics Pitch Proves Perfect 2Pure Plastics Pitch Proves Perfect 3Advanced Life Sciences Announces Third Quarter 2007 Financial Results 2Advanced Life Sciences Announces Third Quarter 2007 Financial Results 3Advanced Life Sciences Announces Third Quarter 2007 Financial Results 4Advanced Life Sciences Announces Third Quarter 2007 Financial Results 5Advanced Life Sciences Announces Third Quarter 2007 Financial Results 6Advanced Life Sciences Announces Third Quarter 2007 Financial Results 7Advanced Life Sciences Announces Third Quarter 2007 Financial Results 8Advanced Life Sciences Announces Third Quarter 2007 Financial Results 9
(Date:9/18/2014)... "frequent flyers" program, fruit flies surely would be eligible ... increasing numbers of fruit fly research studies. One fruit ... and another is scheduled launch to the station Sept. ... December. , Fruit flies are biomedical research models studied ... organisms can reveal the basis for health and disease ...
(Date:9/18/2014)... in DNA, tiny strands of nucleic acid that contain ... this genetic data, our DNA is copied into RNA ... perform tasks in our cells. , Several years ... Unlike all other known RNAs, this molecule is circular, ... abundant, little has been known about how they are ...
(Date:9/18/2014)... so you might expect that most would have an ... dogs are distinctly more pessimistic than others, research from ... is exciting because it measures positive and negative emotional ... and dog owners an insight into the outlook of ... from the Faculty of Veterinary Science. Her PhD research ...
Breaking Biology News(10 mins):Buzzing with activity: Fruit flies orbit Earth for science 2Buzzing with activity: Fruit flies orbit Earth for science 3Buzzing with activity: Fruit flies orbit Earth for science 4Scientists find how mysterious 'circular RNA' is formed, claim muscular dystrophy link 2Dogs can be pessimists too 2Dogs can be pessimists too 3
... from the University of Calgary,s Faculty of Medicine shows ... iPhone application with the same accuracy as a diagnosis ... particularly useful in rural medical settings. This allows for ... where the physicians and patients are located. Neuro-radiologists ...
... TAIPEI, May 9, 2011 /PRNewswire-Asia/ -- PharmaEngine, Inc. and ... agreement under which PharmaEngine grants back to Merrimack the ... the designation of MM-398 by Merrimack) in Asia and ... Under the agreement, PharmaEngine will receive an upfront payment ...
... seeking to understand molecular mechanisms underlying various diseases, notably ... tissues specimen of patients for the expression status of ... expression status of each gene in the genome, measured ... expression profile. Since each of the tens of thousands ...
Cached Biology News:iPhone can diagnose stroke: study 2PharmaEngine, Inc. and Merrimack Pharmaceuticals, Inc. Enter into a Licensing and Collaboration Agreement on PEP02 (MM-398), Nanoliposomal Irinotecan 2Medusa-structure of gene regulatory network: Dominance of transcription factors in cancer subtypes 2Medusa-structure of gene regulatory network: Dominance of transcription factors in cancer subtypes 3Medusa-structure of gene regulatory network: Dominance of transcription factors in cancer subtypes 4
Human DEP-1/CD148 Fluorescein MAb (Clone 143-41) Protein Family: Granulocyte Markers, Monocyte Markers, Phosphatases & Regulators, Other Dendritic Cell Molecules...
An excellent carbonyl-reactive FRET quencher paired with Trp or Tyr. Minimum Purity: 95%. Abs(max): ~350 nm; Em(max): none. Solvent System:DMSO or DMF....
...
...
Biology Products: